Search Results - "Lavernia, Frank"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals by Lavernia, Frank, Adkins, Sarah E., Shubrook, Jay H.

    Published in Postgraduate medicine (01-01-2015)
    “…The management of type 2 diabetes mellitus (T2DM) by primary care physicians (PCPs) has become increasingly complex due to limitations on consultation time, an…”
    Get full text
    Journal Article
  2. 2

    Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes compared with other oral antihyperglycemic agents and placebo by Lavernia, Frank, Blonde, Lawrence

    Published in Postgraduate medicine (16-10-2020)
    “…Oral semaglutide is a tablet formulation of a glucagon-like peptide-1 receptor agonist (GLP-1RA), recently approved in the USA and other countries. This paper…”
    Get full text
    Journal Article
  3. 3

    What options are available when considering starting insulin: premix or basal? by Lavernia, Frank

    Published in Diabetes technology & therapeutics (01-06-2011)
    “…Several large studies in diabetes have shown that early initiation of intensive therapy is better for the prevention of long-term complications and suggest…”
    Get more information
    Journal Article
  4. 4

    A GUIDE TO FOLLOW-ON BIOLOGICS AND BIOSIMILARS WITH A FOCUS ON INSULIN by Dolinar, Richard, Lavernia, Frank, Edelman, Steven

    Published in Endocrine practice (01-02-2018)
    “…Many healthcare providers in the U.S. are not familiar with follow-on biologics and biosimilars nor with their critical distinctions from standard generics…”
    Get more information
    Journal Article
  5. 5

    Are residents receiving the training needed within their residency programs to optimally manage patients with diabetes? by Morales, Javier, Kuritzky, Louis, Lavernia, Frank, Santiago, Michael

    Published in Postgraduate medicine (19-05-2021)
    “…Objective: Diabetes is a prevalent and growing problem in the United States (U.S.); primary care physicians need to be prepared to initiate and progressively…”
    Get full text
    Journal Article
  6. 6

    The non-medical switching of prescription medications by Dolinar, Richard, Kohn, Christine G., Lavernia, Frank, Nguyen, Elaine

    Published in Postgraduate medicine (04-07-2019)
    “…Non-medical switching of medication, whereby a patient's treatment regimen is changed for reasons other than efficacy, side effects, or adherence, is often…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Improving glycemic control and cardiometabolic risk through integrated treatment plans by Lavernia, Frank

    “…Type 2 diabetes mellitus (T2DM) is associated with an increased risk of cardiovascular complications. This increased risk is present even before the diagnosis…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Effective Switch From Premixed to Basal-Prandial Insulin to Achieve Glycemic Goals in Type 2 Diabetes by Lavernia, Frank

    Published in Postgraduate medicine (01-05-2010)
    “…Abstract Objective: This article describes a patient with type 2 diabetes mellitus achieving glycemic control after transitioning from premixed to…”
    Get full text
    Journal Article
  11. 11

    Recognizing and minimizing hypoglycemia: The need for individualized care by Lavernia, Frank, Kushner, Pamela, Trence, Dace, Rice, Donna, Dailey, George, Kuritzky, Louis

    Published in Postgraduate medicine (01-01-2015)
    “…Hypoglycemia is a condition known to disrupt many everyday activities and is associated with increased risks of hospitalization, falls, motor vehicle accidents…”
    Get full text
    Journal Article
  12. 12

    Treating hyperglycemia and diabetes with insulin therapy: transition from inpatient to outpatient care by Lavernia, Frank

    Published in Medscape journal of medicine (2008)
    “…Intensive insulin therapy is recommended to control glucose elevations in the critically ill and has been shown to significantly improve outcomes among…”
    Get full text
    Journal Article
  13. 13

    How to Obtain Appropriate Type 2 Diabetes Control in the First 180 Days of Treatment Initiation by Kuritzky, Louis, Epstein, Benjamin J., Lavernia, Frank

    Published in Postgraduate medicine (01-05-2010)
    “…Good control of diabetes provides meaningful microvascular risk reduction; yet, patients with type 2 diabetes mellitus commonly languish at unsatisfactory…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Type 2 diabetes mellitus: practical approaches for primary care physicians by Gavin, 3rd, James R, Freeman, Jeffrey S, Shubrook, Jr, Jay H, Lavernia, Frank

    “…The incidence and prevalence of type 2 diabetes mellitus (T2DM) have reached epidemic proportions in the United States. In addition to growing numbers of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Surfactant Assisted Dispersion and Adhesion Behavior of Carbon Nanotubes on Cu-Zr and Cu-Zr-Al Amorphous Powders by Nguyen, Jonathan, Wen, Haiming, Zhang, Zhihui, Yaghmaie, Frank, Lavernia, Enrique

    Published in Journal of materials science & technology (01-09-2014)
    “…Carbon nanotubes (CNTs) were dispersed in gas atomized Cu47.5Zr47.5Al5 (CZA) and CusoZrso (CZ) amorphous powders, in an effort to elucidate the mechanisms of…”
    Get full text
    Journal Article